Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 27, 2018 - Indivior and Durect announced the FDA approval of Perseris (risperidone), for the treatment of schizophrenia in adults.
Download PDF
Return to publications
